TrialIndian journal of dermatology, venereology and leprology

A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.

Krishna Pandey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.